For its fourth fiscal quarter (ending December 31), Acadia Pharmaceuticals Inc (NASDAQ: ACAD) has reported E.P.S. of $0.28 compared to $-0.26 a year ago. This result fell short of the consensus estimate of $0.31 by […]
Pinnacle West Capital Corp (NYSE: PNW) has reported E.P.S. of $0.00 for its fourth fiscal quarter (ending December 31) versus $-0.21 for the same period a year ago. This performance was $0.13 better than the […]
Myriad Genetics Inc (NASDAQ: MYGN) has reported E.P.S. of $-0.36 for its fourth fiscal quarter (ending December 31) versus $-0.52 for the same period a year ago. Relative to the consensus estimate of $0.01, this […]
For its fourth fiscal quarter (ending December 31), Ligand Pharmaceuticals Inc (NASDAQ: LGND) has reported E.P.S. of $1.04 compared to $-0.86 a year ago. This performance was $0.38 better than the consensus estimate of $0.66. […]
ICF International Inc (NASDAQ: ICFI) has reported earnings for its fourth fiscal quarter (ending December 31) of $1.18 versus $0.47 for the same period a year ago — an increase of 151%. However, this result […]
HENRY SCHEIN INC (NASDAQ: HSIC) has reported earnings for its fourth fiscal quarter (ending December 31) of $0.13 versus $0.35 for the same period a year ago — a decline of -63%. Relative to the […]
Recent significant negative changes in fundamentals have impacted GeoPark Ltd (NYSE: GPRK): the consensus estimate for December, 2023 decreased significantly, significant quarterly earnings deceleration occurred, and the consensus estimate for December, 2024 decreased significantly. Recent […]
Extremely important negative changes in investment behavior have recently occurred for Finward Bancorp (NASDAQ: FNWD): negative upside/downside volume developed, and its shorter term price trend turned down. Finward Bancorp (NASDAQ: FNWD). Important negative changes in […]
On 2/27/24, Dril-Quip Inc. (NYSE: DRQ) stock enjoyed a major increase of 10.2%, closing at $23.52. Moreover, this advance was accompanied by unusually high trading volume at 191% of normal. Relative to the market the […]
Dorman Products Inc (NASDAQ: DORM) stock closed at $96.26 on 2/27/24 after a major increase of 15.9%. Moreover, trading volume in this advance was exceptionally high at 273% of normal. The stock has risen 17.1% […]
Privacy Statement Terms Of Use ©2024 PriceTarget Research